RETEVMO

Drug Lilly USA, LLC
Total Payments
$1.1M
Transactions
5,166
Doctors
2,685
Companies
3

Payment Trends by Year

Year Amount Transactions Doctors
2024 $122,792 345 283
2023 $375,085 2,324 1,418
2022 $539,935 1,647 819
2021 $23,457 611 466
2020 $4,482 239 219

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $776,288 374 72.8%
Consulting Fee $121,863 50 11.4%
Food and Beverage $120,081 4,298 11.3%
Travel and Lodging $25,363 253 2.4%
Education $22,158 191 2.1%

Top Doctors Receiving Payments for RETEVMO — Page 9

Doctor Specialty Location Total Records
, M.D Hematology & Oncology Flagstaff, AZ $125.00 1
, M.D Medical Oncology Lexington, KY $125.00 1
, MD, PHD Internal Medicine Los Alamitos, CA $125.00 1
Claudia Williams Miami, FL $125.00 1
, MD Hematology & Oncology Pembroke Pines, FL $125.00 1
, ANP Oncology Flagstaff, AZ $125.00 1
, APRN Nurse Practitioner Pembroke Pines, FL $125.00 1
, M.D Specialist Aventura, FL $124.85 1
, M.D Hematology & Oncology Doral, FL $124.85 1
, MD Hematology & Oncology Miami, FL $124.85 1
Nina Nguyen Hematology & Oncology Miami, FL $124.85 1
, MD Hematology & Oncology Auburn, NY $124.74 1
, D.O Medical Oncology Clovis, CA $124.66 1
, MD Internal Medicine Clovis, CA $124.66 1
, NP Family Rancho Mirage, CA $124.33 2
, MD Medical Oncology Columbus, OH $124.25 1
, MD Medical Oncology Columbus, OH $124.25 1
, MD Medical Oncology Columbus, OH $124.25 1
, MD PHD Internal Medicine Renton, WA $124.16 1
, MD Hematology & Oncology Everett, WA $124.16 1
, M.D Internal Medicine Renton, WA $124.16 1
, MD, PHD Internal Medicine Seattle, WA $124.16 1
, MD Hematology & Oncology Renton, WA $124.16 1
, M.D Hematology & Oncology New York, NY $124.07 1
, NP Nurse Practitioner Visalia, CA $123.94 3

About RETEVMO

RETEVMO is a drug associated with $1.1M in payments to 2,685 healthcare providers, recorded across 5,166 transactions in the CMS Open Payments database. The primary manufacturer is Lilly USA, LLC.

Payment data is available from 2020 to 2024. In 2024, $122,792 was paid across 345 transactions to 283 doctors.

The most common payment nature for RETEVMO is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($776,288, 72.8% of total).